Journal
MEDICINAL CHEMISTRY RESEARCH
Volume 20, Issue 7, Pages 898-911Publisher
SPRINGER BIRKHAUSER
DOI: 10.1007/s00044-010-9411-5
Keywords
Synthesis; Piperazine analogues; Antiplatelet aggregation; Molecular modeling studies
Categories
Funding
- King Abdulaziz City for Science and Technology [AR-25-50]
Ask authors/readers for more resources
New carbamoylpyridine and carbamoylpiperidine analogues containing nipecotic acid scaffold were designed, synthesized, and evaluated for their platelet aggregation inhibitory activity. Molecular modeling investigation was performed and the impact of lipophilicity on activity was also discussed. Structure activity relationship among this series was obtained. N (1)-[1-(4-bromobenzyl)-3-piperidino-carbonyl]-N (4)-(2-chlorophenyl)-piperazine hydrobromide (20), and 1,4-bis-[3-[N (4)-(2-chlorophenyl)-N (1)-(piperazino-carbonyl)]-piperidin-1-yl-methyl]-benzene dibromide (30) are the most active antiplatelet aggregating compounds in this study, both at concentration of 0.06 mu M.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available